This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hitachi Chemical Diagnostics Systems Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Mizuki Miura: Innovator in Cholesterol Measurement Technology
Introduction
Mizuki Miura is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the measurement of cholesterol levels in low-density lipoprotein (LDL). His innovative approach emphasizes environmental friendliness while ensuring precision in cholesterol measurement.
Latest Patents
Mizuki Miura holds a patent for a "Method for measuring cholesterol in low-density lipoprotein, measurement reagent, and measurement kit." This patent provides a method for simply and precisely measuring cholesterol (LDL-C) in low-density lipoprotein in a sample without the use of any surfactant having an alkylphenol structure. The method involves reacting the sample with a combination of cholesterol ester hydrolase and cholesterol oxidase or a combination of cholesterol ester hydrolase, an oxidized coenzyme, and cholesterol dehydrogenase in an aqueous solvent. This solvent includes specific surfactants while excluding those with an alkylphenol structure, thereby enhancing environmental safety.
Career Highlights
Mizuki Miura is associated with Hitachi Chemical Diagnostics Systems Co., Ltd., where he applies his expertise in developing innovative diagnostic solutions. His work has led to advancements in cholesterol measurement techniques, contributing to better health outcomes.
Collaborations
Mizuki collaborates with talented individuals such as Tomoko Aratake and Kenta Kinjo. Their teamwork fosters a creative environment that drives innovation in the field of medical diagnostics.
Conclusion
Mizuki Miura's contributions to cholesterol measurement technology reflect his commitment to innovation and environmental responsibility. His work continues to impact the medical diagnostics industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile